Urinary tract infection in urology, including acute and chronic prostatitis. Philadelphia, Pa: Churchill Livingstone 2000. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Epidemiology, pathophysiology, diagnosis, and treatment. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases. New York, NY: McGraw Hill, Inc 2001.ĭembry LM, Andriole VT. Harrison's Principles of Internal Medicine. Infectious diseases and death among nursing home residents: results of surveillance in 13 nursing homes. 28:596-8.īeck-Sague C, Villarino E, Giuliano D, et al. Efficacy of a silicone urinary catheter impregnated with chlorhexidine and triclosan against colonization with Proteus mirabilis and other uropathogens. Effect of triclosan on the formation of crystalline biofilms by mixed communities of urinary tract pathogens on urinary catheters. Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum ß-lactamase-producing Proteus mirabilis. Tsai HY, Chen YH, Tang HJ, Huang CC, Liao CH, Chu FY, et al. Phenotypic and molecular characterization of plasmid mediated AmpC ß-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. Wang JT, Chen PC, Chang SC, Shiau YR, Wang HY, Lai JF, et al. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Lewis JS 2nd, Herrera M, Wickes B, Patterson JE, Jorgensen JH. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management. Luzzaro F, Brigante G, D'Andrea MM, Pini B, Giani T, Mantengoli E, et al.
0 kommentar(er)
